Tuttle Capital Management, LLC Alpha Tau Medical Ltd. Transaction History

Tuttle Capital Management, LLC

  • $10.3 Million
  • Q3 2024

A detailed history of Tuttle Capital Management, LLC transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Tuttle Capital Management, LLC holds 12,221 shares of DRTS stock, worth $37,640. This represents 0.28% of its overall portfolio holdings.

Number of Shares
12,221
Previous 12,221 -0.0%
Holding current value
$37,640
Previous $30,000 3.33%
% of portfolio
0.28%
Previous 0.29%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 13, 2023
BUY
$2.76 - $4.72 $33,729 - $57,683
12,221 New
12,221 $53,000
Q3 2022

Oct 11, 2022
BUY
$0.65 - $11.0 $7,005 - $118,558
10,778 New
10,778 $5,000

Others Institutions Holding DRTS

# of Institutions
29
Shares Held
1.36M
Call Options Held
0
Put Options Held
0
View Full List

About Alpha Tau Medical Ltd.

DRTS Quotes by TradingView
  • Ticker DRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,011,296
  • Market Cap $213M
  • Description
  • Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...
More about DRTS
Track This Portfolio

Track Tuttle Capital Management, LLC Portfolio

Follow Tuttle Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tuttle Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tuttle Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email